Search

Highlights of Past EHA (HOPE) Latin America (LA) 2023 - report

Nov 28 2023 Posted in Meeting reports

October 26, 2023 – São Paulo, Brazil

Meeting chairs:

A Almeida - President EHA

JF Comenalli Marques Jr - President ABHH

C Chiattone - President HEMO 2023

This year, the HOPE LA meeting was held in collaboration with the Associação Brasileira de Hematologia Hemoterapia e…

GoCART Coalition - Call for research proposals within Work Package 6: Scientific Excellence

Apr 23 2021

Dear GoCART community,

With more than 1500 CAR-T infusions registered in the EBMT registry, EHA and EBMT are proud to announce a series of scientific calls within Work Package 6: Scientific Excellence of the GoCART coalition.

Restoring Effective Anti-Tumor Response in Hodgkin Lymphoma with Nivolumab

Jun 10 2016 Posted in Press releases

Hodgkin Lymphoma typically affects young men and women in their 30s. Although it is highly curable with the current combination of chemo and radiation therapy, approximately 20% of patients will not be cured with first line regimens.

Mini-hormone fights iron

Jun 14 2013

Iron overload commonly leads to organ damage and even death. Currently available treatments for iron overload are burdensome or cause side effects.

EBAH CME policy

Welcome to the EBAH CME Accreditation policy for EHA2024 Hybrid Congress. Below you will find an overview of the EBAH CME credits that can be collected for physical attendance as well as virtual attendance of the sessions.

Sponsor opportunities

EHA and the Lebanese Society of Hematology and Blood Transfusion (LSHBT) have initiated a webinar course dedicated to practitioners who manage patients with benign and hematologic malignancies with the practical tools to translate emerging data into the best therapy for…